The basic message of this editorial is that quantum computing and biology are going to meet in unexpected and unexpectedly fruitful ways that will advance both fields quite dramatically. The meeting is still several years away, but when it hits, look out. For example, do not be surprised if someday soon there are prototypes of quantum computing biosensors. The dust is only beginning to settle after the excitement over Pfizer's announcement of a drug called Viagra for treating male impotence. The basic mode of activation of Viagra is to maintain erectile tissue of the penis by controlling blood flow.
Circulatory dysfunction is known to be part of the problem with impotence.
The same issue of circulatory dysfunction also appears to be a key factor to sexual stimulation in females, but that is not certain. So, naturally, discussion turns to whether women would experience similar results from this pill. There are reportedly no studies on how Viagra might affect women. The main contention is that new clinical studies, and much basic research will also need to be done in order to answer fundamental questions about the effect of Viagra on women, and whether it is safe to take. Curiously, this information comes at a time when there is growing discussion about the differences between men and women in such things as perception of pain, how certain drugs are tolerated, and the whole question of whether or not there are many more types of drugs that have to be formulated according to various biological differences between men and women.